Bristol-Myers Squibb (CELG-RI) Stock Analysis

What Bristol-Myers Squibb does

Bristol Myers Squibb Company (BMS) operates as a biopharmaceutical enterprise, managing the entire lifecycle of its therapeutic products, from initial discovery and development to manufacturing, marketing, and distribution. Its diverse portfolio includes conventional small molecule drugs, advanced biologics (which are derived from biological processes), and specialized chimeric antigen receptor (CAR-T) cell therapies. The company was established in August 1933 and maintains its corporate headquarters in Princeton, New Jersey.

Key metrics

ETFs linked to CELG-RI

Broad-market and Healthcare sector ETFs an investor holding Bristol-Myers Squibb is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how CELG-RI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Bristol-Myers Squibb?

Bristol-Myers Squibb trades under the ticker CELG-RI on NYSE.

Which exchange is CELG-RI listed on?

CELG-RI is listed on NYSE.

What sector does Bristol-Myers Squibb operate in?

Bristol-Myers Squibb is classified in the Healthcare sector (Medical - Pharmaceuticals industry).

How can PortView help analyze CELG-RI in a portfolio?

PortView shows CELG-RI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.